493 related articles for article (PubMed ID: 34051661)
1. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling.
Zhang Y; Guo S; Wang S; Li X; Hou D; Li H; Wang L; Xu Y; Ma B; Wang H; Jiang X
Ecotoxicol Environ Saf; 2021 Sep; 220():112376. PubMed ID: 34051661
[TBL] [Abstract][Full Text] [Related]
2. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
3. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
Meng X; Ma J; Wang B; Wu X; Liu Z
J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis.
Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y
Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p.
Wang M; Sun X; Yang Y; Jiao W
Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167
[TBL] [Abstract][Full Text] [Related]
10. POU2F2-mediated upregulation of lncRNA
Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
[TBL] [Abstract][Full Text] [Related]
11. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
Pan C; Chen G; Zhao X; Xu X; Liu J
Eur J Pharmacol; 2022 Nov; 934():175317. PubMed ID: 36216119
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
13. lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer.
Song L; Wang L; Pan X; Yang C
Braz J Med Biol Res; 2020; 53(1):e8883. PubMed ID: 31939597
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
16. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p.
Che Z; Xueqin J; Zhang Z
Bioengineered; 2021 Dec; 12(2):11201-11212. PubMed ID: 34872452
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
18. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
Zhi XH; Jiang K; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
[TBL] [Abstract][Full Text] [Related]
19. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells.
Zou Y; Yao S; Chen X; Liu D; Wang J; Yuan X; Rao J; Xiong H; Yu S; Yuan X; Zhu F; Hu G; Wang Y; Xiong H
Eur J Cell Biol; 2018 Jun; 97(5):369-378. PubMed ID: 29773344
[TBL] [Abstract][Full Text] [Related]
20. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.
Ghafouri-Fard S; Dashti S; Farsi M; Hussen BM; Taheri M
Biomed Pharmacother; 2021 May; 137():111366. PubMed ID: 33601149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
